ArticleOncotarget2014

HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models.

Gaëlle Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.